C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/74 (2006.01) A61K 38/08 (2006.01) A61K 38/10 (2006.01) A61K 38/13 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) C07K 7/04 (2006.01) G01N 33/569 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2187193
Fragments from the polymorphic domains of Class I HLA antigen domains are used to modulate T-cell activity. The peptides are from the .alpha.l- or .alpha.2-domains, particularly of the HLA-A, and B antigens. The peptides may be conjugated to other compounds to be used in diagnosis and therapy. The peptides may block lysis, CTL proliferation or have other regulating effects.
On utilise des fragments provenant des domaines polymorphes des domaines d'antigènes HLA de classe I dans la modulation de l'activité des lymphocytes T. Les peptides proviennent des domaines .alpha.1 ou .alpha.2, notamment des antigènes HLA-A et B. On peut conjuguer les peptides avec d'autres composés en vue d'un usage diagnostique et thérapeutique. Les peptides peuvent bloquer la lyse et la prolifération de lymphocytes T cytotoxiques, ou présenter d'autres effets régulateurs.
Clayberger Carol
Krensky Alan M.
Parham Peter
Fetherstonhaugh & Co.
The Board Of Trustees Of The Leland Stanford Junior University
LandOfFree
Cytotoxic t-cell lymphocyte ("ctl") activity regulation by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytotoxic t-cell lymphocyte ("ctl") activity regulation by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic t-cell lymphocyte ("ctl") activity regulation by... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1477464